Supplemental Materials and Methods from Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis

He Shen,Nuo Yang,Alexander Truskinovsky,Yanmin Chen,Ashley L. Mussell,Norma J. Nowak,Lester Kobzik,Costa Frangou,Jianmin Zhang

DOI: https://doi.org/10.1158/1541-7786.22516207

2023-01-01

Abstract:Supplemental materials and methods

What problem does this paper attempt to address?

Supplementary Materials and Methods from A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells

Siew Wee Chan,Chun Jye Lim,Ke Guo,Chee Peng Ng,Ian Lee,Walter Hunziker,Qi Zeng,Wanjin Hong

DOI: https://doi.org/10.1158/0008-5472.22375602.v1

2023-01-01

Abstract:Supplementary Materials and Methods from A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells
Supplementary Methods from AZ1366: an Inhibitor of Tankyrase and the Canonical Wnt Pathway That Limits the Persistence of Non–Small Cell Lung Cancer Cells Following EGFR Inhibition

Hannah A. Scarborough,Barbara A. Helfrich,Matias Casás-Selves,Alwin G. Schuller,Shaun E. Grosskurth,Jihye Kim,Aik-Choon Tan,Daniel C. Chan,Zhiyong Zhang,Vadym Zaberezhnyy,Paul A. Bunn,James DeGregori

DOI: https://doi.org/10.1158/1078-0432.22463952

2023-01-01

Abstract:Supplementary methods and materials
Supplementary Material and Methods from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers

Huai-Xiang Hao,Hongyun Wang,Chen Liu,Steven Kovats,Roberto Velazquez,Hengyu Lu,Bhavesh Pant,Matthew D. Shirley,Matthew J. Meyer,Minying Pu,Joanne Lim,Michael J. Fleming,LeighAnn Alexander,Ali Farsidjani,Matthew J. LaMarche,Susan E. Moody,Serena J. Silver,Giordano Caponigro,Darrin D. Stuart,Tinya J. Abrams,Peter S. Hammerman,Juliet A. Williams,Jeffrey A. Engelman,Silvia Goldoni,Morvarid Mohseni

DOI: https://doi.org/10.1158/1535-7163.22505919.v1

2023-01-01

Abstract:Supplementary Material and Methods. File contains the following: Transcriptome sequencing and analysis, Soft agar assay, 2D and 3D Cell proliferation screen and compound characterization information.
Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Peng Yuan,Xiao-Hong He,Ye-Fei Rong,Jing Cao,Yong Li,Yun-Ping Hu,Yingbin Liu,Dangsheng Li,Wenhui Lou,Mo-Fang Liu

DOI: https://doi.org/10.1158/0008-5472.22413540.v1

2023-01-01

Abstract:This file contains Materials and Methods that are involved in the figures of the main text and supplementary information. These materials and methods include information of plasmid constructs, cell transfection and viral transduction, RNA preparation and qRT-PCR, luciferase reporter assay, ChIP assay, therapeutic experiments in mice, and immunohistochemistry and in situ hybridization.
Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Tables 1 through 5 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Hong-Lin Jiang,He-Fen Sun,Shui-Ping Gao,Liang-Dong Li,Sheng Huang,Xin Hu,Sheng Liu,Jiong Wu,Zhi-Ming Shao,Wei Jin

DOI: https://doi.org/10.1158/0008-5472.22409469.v1

2023-01-01

Abstract:Supplementary Materials and Methods, Supplementary Figure Legends, Supplementary Table S1 Alteration of SSBP1 protein expression levels in relation to clinicopathological characteristics in breast cancer patients. Supplementary Table S2 Antibodies used in this study. Supplementary Table S3 Primers for plasmid construction. Supplementary Table S4 Primers for ChIP. Supplementary Table S5 iTRAQ: Dysregulated proteins with gene symbol.
Supplemental Methods from Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis

Hong Zhu,Dan-Dan Wang,Tao Yuan,Fang-Jie Yan,Chen-Ming Zeng,Xiao-Yang Dai,Zi-bo Chen,Ying Chen,Tianyi Zhou,Guang-Han Fan,Meidan Ying,Ji Cao,Peihua Luo,Xi-Jie Liu,Yuandong Hu,Yong Peng,Qiaojun He,Bo Yang

DOI: https://doi.org/10.1158/0008-5472.22417226.v1

2023-01-01

Abstract:Materials and Methods for Supplemental Figures
Supplemental Materials and Methods from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies

Yu-Wei Li,Lei-Jie Dai,Xiang-Rong Wu,Shen Zhao,Yu-Zheng Xu,Xi Jin,Yi Xiao,Ying Wang,Cai-Jin Lin,Yi-Fan Zhou,Tong Fu,Wen-Tao Yang,Ming Li,Hong Lv,Siyuan Chen,Anita Grigoriadis,Yi-Zhou Jiang,Ding Ma,Zhi-Ming Shao

DOI: https://doi.org/10.1158/0008-5472.27603358

2024-01-01

Abstract:Supplemental Materials and Methods
Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

PengXu Qian,Arindam Banerjee,Zheng-Sheng Wu,Xiao Zhang,Hong Wang,Vijay Pandey,Wei-Jie Zhang,Xue-Fei Lv,Sheng Tan,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22395995

2023-01-01

Abstract:PDF file - 190K, Includes patient and specimen data, reagent information, miRNA and siRNA transfection, and statistical analysis. Also includes supplementary references
Supplementary materials and methods from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Jialei Weng,Zheng Wang,Zhiqiu Hu,Wenxin Xu,Jia-Lei Sun,Fu Wang,Qiang Zhou,Shaoqing Liu,Min Xu,Minghao Xu,Dongmei Gao,Ying-Hao Shen,Yong Yi,Yi Shi,Qiongzhu Dong,Chenhao Zhou,Ning Ren

DOI: https://doi.org/10.1158/0008-5472.25964576.v1

2024-01-01

Abstract:Supplementary materials and methods
Supplementary Methods, Figures S1-14 from Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor–Positive Breast Cancer

James R. Whittle,François Vaillant,Elliot Surgenor,Antonia N. Policheni,Göknur Giner,Bianca D. Capaldo,Huei‐Rong Chen,He K. Liu,Johanna F. Dekkers,Norman Sachs,Hans Clevers,Andrew Fellowes,Thomas Green,Huiling Xu,Stephen B. Fox,Marco J. Herold,Gordon K. Smyth,Daniel H.D. Gray,Jane E. Visvader,Geoffrey J. Lindeman

DOI: https://doi.org/10.1158/1078-0432.22475475

2023-01-01

Abstract:Supplemental Methods and Figures
Supplementary Materials, Methods and Tables from Downregulation of safb Sustains the NF-κB Pathway by Targeting tak1 During the Progression of Colorectal Cancer

Hong‐Li Jiao,Yaping Ye,Runwei Yang,Hongbin Sun,Shuyang Wang,Yongxia Wang,Zhi-Yuan Xiao,Long He,Juan‐Juan Cai,Wanzhi Wei,Yanru Chen,Chun-Cai Gu,Yue-Long Cai,Yun-Teng Hu,Qiuhua Lai,Junfeng Qiu,Liang Li,Guangwen Cao,Wenting Liao,Yan‐Qing Ding

DOI: https://doi.org/10.1158/1078-0432.22463628.v1

2023-01-01

Abstract:Supplementary materials, methods and tables
Supplementary Methods and Materials, Figure Legend from ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM

Xuesong Liu,Matthew Genet,Jenna E. Haines,Elie K. Mehanna,Shanshan Wu,Hung-I Harry Chen,Yidong Chen,Abrar A. Qureshi,Jiali Han,Xiang Chen,David E. Fisher,Pier Paolo Pandolfi,Yuan Zhang

DOI: https://doi.org/10.1158/1541-7786.22514197

2023-01-01

Abstract:Supplementary Methods and Materials, Figure Legend
Supplementary Materials SM1 from Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, is Highly Active Against Triple-Negative Breast Cancer

Peng,Xiaoyan Qiang,Guoyu Li,Lin Li,Shumao Ni,Qi Yu,Laura Sourd,Elisabetta Marangoni,Chao Hu,Dong Wang,Di Wu,Frank Wu

DOI: https://doi.org/10.1158/1535-7163.22523257.v1

2023-01-01

Abstract:This includes the supplementary methods and supplementary table captions.
Supplemental Materials and Methods and Supplemental Figure Legends from Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

Bryan Wei Chen,Wei Chen,Hui Liang,Hao Liu,Chao Liang,Xiao Zhi,Li-qiang Hu,Xia-Zhen Yu,Tao Wei,Tao Ma,Fei Xue,Lei Zheng,Bin Zhao,Xin-Hua Feng,Xue-li Bai,Ting-bo Liang

DOI: https://doi.org/10.1158/1535-7163.22502419

2023-01-01

Abstract:Supplemental Materials and Methods and Supplemental Figure Legends
Supplementary Materials & Methods from Targeted Therapy of &Lt;i>tert-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

Jingwei Chen,Christopher P. Nelson,Matthew Wong,Andrew E. Tee,Pei Y. Liu,Ting La,Jamie I. Fletcher,Alvin Kamili,Chelsea Mayoh,Christoph Bartenhagen,Toby N. Trahair,Ning Xu,Nisitha Jayatilleke,Marie Wong,Pei Hui,Bernard Atmadibrata,Belamy B. Cheung,Qing Lan,Tracy M. Bryan,Pieter Mestdagh,Jo Vandesompele,Valérie Combaret,Valentina Boeva,Jenny Wang,Isabelle Janoueix-Lerosey,Mark J. Cowley,Karen L. MacKenzie,Alla Dolnikov,Jinyan Li,Patsie Polly,Glenn M. Marshall,Roger R. Reddel,Murray D. Norris,Michelle Haber,Matthias Fischer,Xu Dong Zhang,Hilda A. Pickett,Tao Liu

DOI: https://doi.org/10.1158/1078-0432.22479831.v1

2023-01-01

Abstract:Re - Revised Supplementary Materials & Methods
Supplementary Methods from Flightless-I Blocks P62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression

Jian-Ping He,Pei-Pei Hou,Qi-Tao Chen,Wei-Jia Wang,Xiao-Yu Sun,Peng-Bo Yang,Ying-Ping Li,Lu-Ming Yao,Xiaotong Li,Xin-Dong Jiang,Kun-Yi Chien,Zhi-Ming Zhang,Qiu-Wan Wu,Allison J. Cowin,Qiao Wu,Hang-Zi Chen

DOI: https://doi.org/10.1158/0008-5472.22425894

2023-01-01

Abstract:Supplementary materials and methods and supplementary figure legends.
Supplementary Methods and Materials from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells

Tobias Schatton,Ute Schütte,Natasha Y. Frank,Qian Zhan,André Hoerning,Susanne C. Robles,Jun Zhou,F. Stephen Hodi,Giulio C. Spagnoli,George F. Murphy,Markus H. Frank

DOI: https://doi.org/10.1158/0008-5472.22384290

2023-01-01

Abstract:Supplementary Methods and Materials from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
Supplementary Figures from Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion

Tsung-Chieh Shih,Ruiwu Liu,Chun-Te Wu,Xiaocen Li,Wenwu Xiao,Xiaojun Deng,Sophie Kiss,Ting Wang,Xiao-Jia Chen,Randy Carney,Hsing-Jien Kung,Yong Duan,Paramita M. Ghosh,Kit S. Lam

DOI: https://doi.org/10.1158/1078-0432.22470459.v1

2023-01-01

Abstract:Supplementary materials and methods
Supplementary Materials and Methods from Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis

Xiaohu Zheng,Min Cheng,Binqing Fu,Xiaolei Fan,Qing Wang,Xiaoqing Yu,Rui Sun,Zhigang Tian,Haiming Wei

DOI: https://doi.org/10.1158/0008-5472.22407629.v1

2023-01-01

Abstract:Supplementary Materials and Methods

Supplemental Materials and Methods from Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis

Supplementary Materials and Methods from A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells

Supplementary Methods from AZ1366: an Inhibitor of Tankyrase and the Canonical Wnt Pathway That Limits the Persistence of Non–Small Cell Lung Cancer Cells Following EGFR Inhibition

Supplementary Material and Methods from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers

Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Tables 1 through 5 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Supplemental Methods from Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis

Supplemental Materials and Methods from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies

Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary materials and methods from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Supplementary Methods, Figures S1-14 from Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor–Positive Breast Cancer

Supplementary Materials, Methods and Tables from Downregulation of <i>safb</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>tak1</i> During the Progression of Colorectal Cancer

Supplementary Methods and Materials, Figure Legend from ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM

Supplementary Materials SM1 from Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, is Highly Active Against Triple-Negative Breast Cancer

Supplemental Materials and Methods and Supplemental Figure Legends from Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

Supplementary Materials & Methods from Targeted Therapy of &Lt;i>tert</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

Supplementary Methods from Flightless-I Blocks P62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression

Supplementary Methods and Materials from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells

Supplementary Figures from Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion

Supplementary Materials and Methods from Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis

Supplemental Materials and Methods from Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis

Supplementary Materials and Methods from A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells

Supplementary Methods from AZ1366: an Inhibitor of Tankyrase and the Canonical Wnt Pathway That Limits the Persistence of Non–Small Cell Lung Cancer Cells Following EGFR Inhibition

Supplementary Material and Methods from Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers

Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Tables 1 through 5 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Supplemental Methods from Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis

Supplemental Materials and Methods from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies

Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary materials and methods from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Supplementary Methods, Figures S1-14 from Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor–Positive Breast Cancer

Supplementary Materials, Methods and Tables from Downregulation of &lt;i&gt;safb&lt;/i&gt; Sustains the NF-&lt;b&gt;κ&lt;/b&gt;B Pathway by Targeting &lt;i&gt;tak1&lt;/i&gt; During the Progression of Colorectal Cancer

Supplementary Methods and Materials, Figure Legend from ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM

Supplementary Materials SM1 from Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, is Highly Active Against Triple-Negative Breast Cancer

Supplemental Materials and Methods and Supplemental Figure Legends from Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

Supplementary Materials &amp; Methods from Targeted Therapy of &Lt;i&gt;tert&lt;/i&gt;-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

Supplementary Methods from Flightless-I Blocks P62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression

Supplementary Methods and Materials from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells

Supplementary Figures from Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion

Supplementary Materials and Methods from Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis

Supplementary Materials, Methods and Tables from Downregulation of <i>safb</i> Sustains the NF-<b>κ</b>B Pathway by Targeting <i>tak1</i> During the Progression of Colorectal Cancer

Supplementary Materials & Methods from Targeted Therapy of &Lt;i>tert</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy